Full-Time

Director Specialty Hub Pharmacy

Deadline 4/28/27
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based and community health services, pharmacy

Compensation Overview

$150k - $180k/yr

Denver, CO, USA

In Person

Denver, CO-based role with 0-25% travel.

Category
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • 8+ years of progressive leadership experience in specialty pharmacy, hub services, or related healthcare operations
  • Experience managing national or multi-site operations
  • Deep understanding of specialty pharmacy workflows, payer requirements, and access processes
  • Data-driven mindset with experience using metrics to guide performance
  • Excellent communication, collaboration, and stakeholder management skills
  • Percentage of Travel: 0-25%
Responsibilities
  • Provides national oversight of Specialty Hub operations, including intake, benefits investigation, prior authorization, and patient onboarding
  • Leads specialty pharmacy operations to ensure efficient dispensing, care coordination, and adherence to clinical protocols
  • Develops and implements scalable processes to support growth and operational efficiency
  • Establishes and monitors KPIs related to turnaround times, access success rates, patient satisfaction, and financial performance
  • Directs the Specialty Access Team to ensure timely and accurate benefits verification, authorization, and financial assistance coordination
  • Optimizes patient access workflows to minimize delays in therapy initiation
  • Collaborates with payers, manufacturers, and internal stakeholders to improve access outcomes
  • Partners with executive leadership to define and execute the specialty hub strategy
  • Identifies opportunities for service expansion, innovation, and improved patient experience
  • Supports business development initiatives, including payer and manufacturer partnerships
  • Leads, mentors, and develops a high-performing team across operations and access functions
  • Fosters a culture of accountability, collaboration, and continuous improvement
  • Ensures appropriate staffing models and organizational structure to support national operations
  • Ensures adherence to all federal and state regulations, accreditation standards (e.g., URAC, ACHC), and company policies
  • Maintains audit readiness and oversee quality assurance programs
  • Promotes a culture of patient safety and regulatory compliance
  • Manages budget and financial performance for specialty hub operations
  • Drives cost efficiencies while maintaining high-quality patient care
  • Utilizes data analytics to inform decision-making and performance improvements
Desired Qualifications
  • Pharmacist license preferred, not required
  • Active pharmacist license in good standing (if applicable); multi-state licensure preferred
  • Experience with specialty pharmacy accreditation standards and regulatory requirements
  • Strong leadership and team development capabilities
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue grew 25.6% to $3.61 billion.[1]
  • Specialty and infusion pharmacy revenue rose 35.5% year over year.[1]
  • Management raised full-year 2026 guidance after beating EPS and revenue estimates.[1]

What critics are saying

  • Heavy dependence on Medicare and Medicaid reimbursement exposes margins to rate pressure.[1][2]
  • Integration of Amedisys and LHC branches can distract management and delay synergies.[1]
  • Insider selling by Jon Rousseau and Lisa Nalley signals limited near-term confidence.[1]

What makes BrightSpring Health Services unique

  • Integrated pharmacy and provider services target complex chronic-care populations.[1][2]
  • National scale spans Pharmacy, Provider, and Managed Care services.[2][4]
  • Technology-enabled care delivery supports outcomes across home and community settings.[1][2]

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at BrightSpring Health Services who can refer or advise you

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

4%
Yahoo Finance
Apr 10th, 2026
BrightSpring Health shares jump 5.2% on 15-20% EBITDA growth targets and AI efficiency plans

BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.

Yahoo Finance
Mar 30th, 2026
BrightSpring Health Services stock surges 43% in 6 months, but low ROIC raises concerns

BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.

Yahoo Finance
Mar 25th, 2026
BrightSpring trades at 24.5x forward P/E despite $600M revenue headwinds

BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.

Yahoo Finance
Mar 24th, 2026
BrightSpring tops Q4 senior health earnings as Chemed's $639M revenue disappoints

BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.

Yahoo Finance
Mar 19th, 2026
BrightSpring projects sub-2x leverage in 2026, unveils $2B M&A firepower and integrated care strategy

BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.